haspete chart please, page-108

thanks pete. much appreciated.


Dr Geoff Cummings will also be presenting at Southern cross equities Life sciences conference at 2pm.

(http://www.asx.com.au/documents/resources/Life_Sciences_Conference_Programme_2011_.pdf)


Summary of Anteo Diagnostics (from April 2011 presentation)

Mix&Go? is a proven and commercialised technology
Bangs and Merck already using the technology

Mix&Go? now targeting an established market - IVD (pathology) immunoassay market valued at $8 billion

Mix&Go? being tested by healthcare companies in multiple sectors - pathology (IVD), research, point of care, diagnostics, immunoprecipitation

More than 50 leading healthcare companies currently testing and assessing the technology ? not one has said no

Mix&Go? has multiple applications outside of healthcare

ADO well funded with $7.3 million in cash ? potential to access current market opportunities with current cash position